Skip to content

Questionnaire Survey for the Impact of COVID-19 Crisis on Patients with Parkinson's Disease and their Caregivers

Questionnaire Survey for the Impact of COVID-19 Crisis on Patients with Parkinson's Disease and their Caregivers - Questionnaire Survey for the Impact of COVID-19 on Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043167
Enrollment
3000
Registered
2021-01-29
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Sponsors

Takeda Pharmaceutical Company Limited.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects must fulfill all of the following criteria: 1) Patients themselves or patients to be cared who belong to Japan Parkinson's Disease Association 2) Patients or caregivers who agree to participate in the survey and to publish the survey results

Exclusion criteria

Exclusion criteria: No matching the key inclusion criteria

Design outcomes

Primary

MeasureTime frame
Survey in patients: Pattern of outpatient visit and treatment, lifestyle, PD symptoms before and after COVID-19 pandemic Survey in caregivers: Lifestyle, burden and health status of caregivers before and after COVID-19 pandemic

Countries

Japan

Contacts

Public ContactYayoi Kawata

Takeda Pharmaceutical Company Limited. Japan Medical Office

yayoi.kawata@takeda.com03-3278-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026